| 1999: |
 August 19 |
 |
Immune Network Enters Into Joint Venture With Inexsis |
| August 12 |
|
Immune Network & Bridge Pharma Form Joint Venture |
| August 6 |
|
Completion of 1F7 Viral Load Testing |
| July 26 |
|
IMM engages E&Y and ICP |
| July 20 |
|
Option Agreement with the University of British Columbia |
| July 14 |
|
Immune Network Research Non-Brokered Private Placements Close |
| June 11 |
|
Corporate Update |
| May 31 |
|
Private Placement |
| May 21 |
|
New Management, Financing and other Corporate Developments |
| April 13 |
|
Changes in Management |
| February 3 |
|
Phase II Preclinical Study |
| 1998: |
| December 21 |
|
Antibody Patent Issued |
| December 7 |
|
Private Placement Announcement |
| November 3 |
|
Primate Study Nears Completion |
| September 23 |
|
Primate Study Expanded |
| July 20 |
|
Scientific Advisory Board and Research |
| July 2 |
|
Research Progress Reported at the Annual General Meeting |
| June 22 |
|
Primate Research Progress Report |
| May 25 |
|
Private Placement and Appointment of Officer |
| May 20 |
|
Corporate Update |
| May 8 |
|
Second Phase of mAb 1F7 Study in Progress |
| April 14 |
|
Second Phase of mAb 1F7 Injection in Primate Model |
Below is an archive of news releases announced by INR. If you would like to be automatically notified the moment a news release is added to INR's web site, register with NewsNOW!, INR's e-mail alert service.